Journal Club - Recent Additions

May - 2021

Previous Next    

Showing Journal 8 of 10

Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome

F Wong, C Pappas, M Curry, et al for the CONFIRM Study Investigators New Eng J Med, 2021, 384:818-828


Terlipressin is a synthetic vasopressin analogue with vasoconstrictor activity in the splanchnic and systemic vasculature, resulting in decreased portal blood inflow and reduced portal hypertension, the main cause of the hemodynamic abnormalities associated with advanced cirrhosis....


Previous Comments

No Comments yet.